SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS EFTRENONACOG ALFA, PEGCETACOPLAN, AVATROMBOPAG, ANAKINRA, VOLANESORSEN, ECULIZUMAB, SELUMETINIB, RAMUCIRUMAB, BARICITINIB, SELPERCATINIB, IXEKIZUMAB, ABEMACICLIB, DOSTARLIMAB, ASCIMINIB, INCLISIRAN, TREPROSTINIL Y TRASTUZUMAB DERUXTECAN, PRIMERA PARTE LOTES 1-16

Contract type	Supplies
CPV	33650000
Awarded to	LILLY, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.